FI930509A - Anvaendning av graensytpolymeriserade membraner i doseringsanordningar - Google Patents

Anvaendning av graensytpolymeriserade membraner i doseringsanordningar Download PDF

Info

Publication number
FI930509A
FI930509A FI930509A FI930509A FI930509A FI 930509 A FI930509 A FI 930509A FI 930509 A FI930509 A FI 930509A FI 930509 A FI930509 A FI 930509A FI 930509 A FI930509 A FI 930509A
Authority
FI
Finland
Prior art keywords
pct
membraner
dosering
polymerizer
graphic
Prior art date
Application number
FI930509A
Other languages
English (en)
Other versions
FI930509A0 (fi
FI108610B (fi
Inventor
Scott Max Herbig
Richard Wilker Korsmeyer
Avinash Govind Thombre
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI930509A publication Critical patent/FI930509A/fi
Publication of FI930509A0 publication Critical patent/FI930509A0/fi
Application granted granted Critical
Publication of FI108610B publication Critical patent/FI108610B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
FI930509A 1990-08-07 1993-02-05 Rajapintapolymeroitujen membraanien käyttö annosteluvälineissä FI108610B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US56400890A 1990-08-07 1990-08-07
US56400890 1990-08-07
US9105337 1991-08-01
PCT/US1991/005337 WO1992002212A2 (en) 1990-08-07 1991-08-01 Use of interfacially-polymerized membranes in delivery devices

Publications (3)

Publication Number Publication Date
FI930509A true FI930509A (fi) 1993-02-05
FI930509A0 FI930509A0 (fi) 1993-02-05
FI108610B FI108610B (fi) 2002-02-28

Family

ID=24252794

Family Applications (1)

Application Number Title Priority Date Filing Date
FI930509A FI108610B (fi) 1990-08-07 1993-02-05 Rajapintapolymeroitujen membraanien käyttö annosteluvälineissä

Country Status (13)

Country Link
US (1) US5876752A (fi)
EP (1) EP0542926B1 (fi)
JP (1) JPH0794379B2 (fi)
AT (1) ATE118345T1 (fi)
CA (1) CA2087435C (fi)
DE (2) DE69107461T2 (fi)
DK (1) DK0542926T3 (fi)
ES (1) ES2067957T3 (fi)
FI (1) FI108610B (fi)
GR (1) GR3015731T3 (fi)
IE (1) IE65403B1 (fi)
PT (1) PT98571B (fi)
WO (1) WO1992002212A2 (fi)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA933725B (en) * 1992-05-28 1993-12-15 Elan Corp Plc Tablet formulation
WO1994012159A1 (en) * 1992-11-30 1994-06-09 Pfizer Inc. Supported liquid membrane delivery devices
ES2120354B1 (es) * 1996-02-12 1999-07-01 Univ Sevilla Dispositivo terapeutico para direccionar farmacos hacia el tramo del tracto gastrointestinal deseado en funcion de las caracteristicas fisicoquimicas del mismo.
EP0811374A1 (en) * 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
KR100446366B1 (ko) 1997-07-01 2004-09-01 화이자 인코포레이티드 서트랄린 염 및 서트랄린의 서방성 투여형
US20030133974A1 (en) * 1997-07-01 2003-07-17 Curatolo William John Encapsulated solution dosage forms of sertraline
PT1035834E (pt) * 1997-12-05 2002-09-30 Alza Corp Forma de dosagem osmotica que compreende primeiro e segundo revestimentos
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
JP2002531491A (ja) 1998-12-11 2002-09-24 ノストラム・ファーマスーティカルズ・インコーポレイテッド ヒドロコロイドおよびセルロースエーテルを含む持続放出性錠剤
GB9923045D0 (en) * 1999-09-29 1999-12-01 Novartis Ag New oral formulations
US6613357B2 (en) * 2000-01-13 2003-09-02 Osmotica Corp. Osmotic device containing pseudoephedrine and an H1 antagonist
JP2003521507A (ja) * 2000-02-04 2003-07-15 ディポメド，インコーポレイティド ゼロ次薬物放出に接近するシェル−コア剤形
US6616652B1 (en) 2000-02-15 2003-09-09 Microsolutions, Inc. Osmotic pump delivery system with pre-hydrated membrane(s) and/or primable catheter
US6464688B1 (en) 2000-02-15 2002-10-15 Microsolutions, Inc. Osmotic pump delivery system with flexible drug compartment
AU2002220248A1 (en) * 2000-11-06 2002-05-15 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
US6632217B2 (en) 2001-04-19 2003-10-14 Microsolutions, Inc. Implantable osmotic pump
IL159287A0 (en) * 2001-06-28 2004-06-01 Ucb Farchim Sa Tablet comprising cetirizine and pseudoephedrine
DE60319685T2 (de) 2002-04-04 2009-03-26 Pfizer Products Inc., Groton Wohlschmeckende kautablette
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
US20040131672A1 (en) * 2003-01-07 2004-07-08 Nilobon Podhipleux Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
RS20060132A (en) * 2003-08-08 2008-06-05 Biovail Laboratories International Srl., Modified-release tablet of bupropion hydrochloride
US20060200250A1 (en) * 2005-03-04 2006-09-07 Ku David N Biocompatible implant device
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
RU2008151945A (ru) * 2006-06-01 2010-07-20 Шеринг Корпорейшн (US) Лекарственные формы с пульсирующим высвобождением и фармацевтические композиции фенилэфрина
PL2034970T3 (pl) * 2006-06-01 2012-12-31 Msd Consumer Care Inc Preparat farmaceutyczny o przedłużonym uwalnianiu zawierający fenylefrynę
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
AR061166A1 (es) * 2006-06-01 2008-08-06 Schering Corp Composiciones farmaceuticas para la liberacion sostenida de fenilferina
US20080299186A1 (en) * 2007-06-01 2008-12-04 Schering-Plough Healthcare Products, Inc. Coatings for applying substances onto substrate carrier
PE20091084A1 (es) * 2007-12-07 2009-07-23 Schering Plough Healthcare Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal
US8857629B2 (en) 2010-07-15 2014-10-14 International Business Machines Corporation Composite membrane with multi-layered active layer
US9022227B2 (en) 2011-03-21 2015-05-05 International Business Machines Corporation Composite membranes and methods of preparation thereof
US9561474B2 (en) 2012-06-07 2017-02-07 International Business Machines Corporation Composite membrane with multi-layered active layer
JP6532010B2 (ja) * 2015-03-25 2019-06-19 トッパン・フォームズ株式会社 マイクロカプセル、シート、樹脂組成物及び液状組成物
WO2021156698A1 (en) 2020-02-03 2021-08-12 Johnson & Johnson Consumer Inc. A single layer chewable tablet comprising cetirizine

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL271831A (fi) * 1960-11-29
US3270100A (en) * 1962-08-01 1966-08-30 Delvan Mfg Company Method for making capsules by interfacial polymerization
US3577515A (en) * 1963-12-13 1971-05-04 Pennwalt Corp Encapsulation by interfacial polycondensation
US3615536A (en) * 1968-01-02 1971-10-26 Eastman Kodak Co Photographic element and process having a light-sensitive metal complex
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
US3995631A (en) * 1971-01-13 1976-12-07 Alza Corporation Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient
US3875074A (en) * 1972-03-06 1975-04-01 Champion Int Corp Formation of microcapsules by interfacial cross-linking of emulsifier, and microcapsules produced thereby
US3884801A (en) * 1972-05-02 1975-05-20 Us Interior Preparation of reverse osmosis membranes by complete evaporation of the solvent system
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3952741A (en) * 1975-01-09 1976-04-27 Bend Research Inc. Controlled release delivery system by an osmotic bursting mechanism
US4056610A (en) * 1975-04-09 1977-11-01 Minnesota Mining And Manufacturing Company Microcapsule insecticide composition
US3977404A (en) * 1975-09-08 1976-08-31 Alza Corporation Osmotic device having microporous reservoir
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4016880A (en) * 1976-03-04 1977-04-12 Alza Corporation Osmotically driven active agent dispenser
HU174057B (hu) * 1976-09-17 1979-10-28 Richter Gedeon Vegyeszet Sostav dlja pokrytij obespechivajuhhij uregulirovannuju otdachy aktivnogo vehhestva biologicheski aktivnykh preparatov i sposob poluchenija takikh preparatov s uregulirovannoj otdachej aktivnogo vehhestva
US4203439A (en) * 1976-11-22 1980-05-20 Alza Corporation Osmotic system with volume amplifier for increasing amount of agent delivered therefrom
GB1544761A (en) * 1976-11-26 1979-04-25 Pennwalt Corp Prolonged release pharmaceutical preparations
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4251387A (en) * 1979-04-17 1981-02-17 Damon Corporation Process for preparing semipermeable microcapsules
IL59063A (en) * 1979-01-11 1983-12-30 Key Pharma Polymeric diffusion matrix for release of pharmaceutical dosage
US4235236A (en) * 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
US4423009A (en) * 1980-04-02 1983-12-27 Aluminium Pechiney Carbonate, sulphate and hydroxide or hydrogen carbonate
DE3020781C2 (de) * 1980-05-31 1982-11-18 Hoechst Ag, 6000 Frankfurt Druckbeständige Mikrokapseln mit einer Polyamid-Außenhülle und einer durch Polyurethan-Polyharnstoff oder Polyharnstoff strukturierten Innenmasse und Verfahren zu ihrer Herstellung
US4333972A (en) * 1980-06-25 1982-06-08 Puropore, Inc. Highly anisotropic membranes
DE3167521D1 (en) * 1981-01-22 1985-01-17 Capsugel Ag A process for producing a pharmaceutical capsule having enteric properties
ATE14379T1 (de) * 1981-04-27 1985-08-15 Haessle Ab Pharmazeutisches praeparat.
ZA822995B (en) * 1981-05-21 1983-12-28 Wyeth John & Brother Ltd Slow release pharmaceutical composition
FR2514261B1 (fr) * 1981-10-08 1986-08-22 Aec Chim Organ Biolog Nouvelle composition pour l'enrobage des aliments et des medicaments et granules ainsi enrobes
JPS58134019A (ja) * 1982-02-05 1983-08-10 Ono Pharmaceut Co Ltd プロスタグランジン含有持続放出型三層状フイルム製剤及びその製造方法
US4439196A (en) * 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4455143A (en) * 1982-03-22 1984-06-19 Alza Corporation Osmotic device for dispensing two different medications
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
US4557925A (en) * 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
US4576604A (en) * 1983-03-04 1986-03-18 Alza Corporation Osmotic system with instant drug availability
US4673405A (en) * 1983-03-04 1987-06-16 Alza Corporation Osmotic system with instant drug availability
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
GB8322007D0 (en) * 1983-08-16 1983-09-21 Wellcome Found Pharmaceutical delivery system
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
US4563212A (en) * 1983-12-27 1986-01-07 Monsanto Company High concentration encapsulation by interfacial polycondensation
US4643764A (en) * 1984-01-09 1987-02-17 Stauffer Chemical Company Multiple types of microcapsules and their production
DE3404310A1 (de) * 1984-02-08 1985-08-08 Henkel KGaA, 4000 Düsseldorf Verwendung von salicylsaeureestern als riechstoffe und diese enthaltende riechstoffkompositionen
US4684524A (en) * 1984-03-19 1987-08-04 Alza Corporation Rate controlled dispenser for administering beneficial agent
NL8401912A (nl) * 1984-06-15 1986-01-02 Tno Met aktieve stof beladen biodegradeerbare polymeersubstraten, geschikt voor het gecontroleerd afgeven van de aktieve stof door middel van een membraan.
CA1239034A (en) * 1984-08-17 1988-07-12 Kelly L. Smith Delivery system
US4629620A (en) * 1984-09-05 1986-12-16 Ab Ferrosan Membrane-coated sustained-release tablets and method
US4629619A (en) * 1984-09-05 1986-12-16 Ab Ferrosan Membrane-coated sustained-release tablets and method
SE8404467D0 (sv) * 1984-09-06 1984-09-06 Ferrosan Ab Controlled-release medical preparations
BR8506634A (pt) * 1984-12-20 1986-09-09 Rhone Poulenc Sante Composicoes para o revestimento de aditivos alimentares destinados aos ruminantes e granulados sob forma de microcapsulas assim revestidos
FR2577227B1 (fr) * 1985-02-11 1987-05-15 Inst Nat Rech Chimique Membranes asymetriques ou composites a base de polyquinoxalines, leur application possible en permeation gazeuse et plus particulierement pour le fractionnement des melanges gazeux, et notamment la deshydratation et la desacidification des gaz, specialement les hydrocarbures gazeux
IE59066B1 (en) * 1985-02-19 1993-12-15 Key Pharma Controlled release potassium chloride
US4609374A (en) * 1985-04-22 1986-09-02 Alza Corporation Osmotic device comprising means for governing initial time of agent release therefrom
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
US4693896A (en) * 1985-10-07 1987-09-15 Fmc Corporation Ethylcellulose-coated, gastric-disintegrable aspirin tablet
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release
JPS62163702A (ja) * 1986-01-14 1987-07-20 Nok Corp 界面重合逆浸透膜
JPS62197183A (ja) * 1986-02-24 1987-08-31 Nisshinbo Ind Inc 表面多孔性プラスチツクシ−トの製造方法
ES2019634B3 (es) * 1986-04-17 1991-07-01 Alza Corp Terapia con clorfeniramina.
US4816264A (en) * 1986-06-06 1989-03-28 Warner-Lambert Company Sustained release formulations
US4786500A (en) * 1986-06-26 1988-11-22 Alza Corporation Programmable agent delivery system
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
US4767789A (en) * 1986-10-21 1988-08-30 American Home Products Corporation (Del.) Spray dried acetaminophen
US4828705A (en) * 1986-10-31 1989-05-09 Kingston Technologies, Inc. Pressure-dependent anisotropic-transport membrane system
US4954381A (en) * 1986-12-30 1990-09-04 The Research Foundation Of The State University Of New York Preparation of porous substrates having well defined morphology
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane

Also Published As

Publication number Publication date
JPH0794379B2 (ja) 1995-10-11
ES2067957T3 (es) 1995-04-01
DE9190107U1 (de) 1993-12-16
US5876752A (en) 1999-03-02
DK0542926T3 (da) 1995-05-15
DE69107461D1 (de) 1995-03-23
FI930509A0 (fi) 1993-02-05
GR3015731T3 (en) 1995-07-31
WO1992002212A2 (en) 1992-02-20
EP0542926B1 (en) 1995-02-15
DE69107461T2 (de) 1995-06-22
IE65403B1 (en) 1995-10-18
WO1992002212A3 (en) 1992-04-02
FI108610B (fi) 2002-02-28
CA2087435C (en) 1998-05-05
ATE118345T1 (de) 1995-03-15
CA2087435A1 (en) 1992-02-08
PT98571A (pt) 1993-09-30
EP0542926A1 (en) 1993-05-26
JPH05509107A (ja) 1993-12-16
IE912781A1 (en) 1992-02-12
PT98571B (pt) 1999-03-31

Similar Documents

Publication Publication Date Title
FI930509A0 (fi) Anvaendning av graensytpolymeriserade membraner i doseringsanordningar
DK0663820T3 (da) Farmaceutisk tablet, som er i stand til at frigive ét eller flere lægemidler med forskellige frigivelseshastigheder
ATE64091T1 (de) Tablette mit verzoegerter freisetzung.
SE9402422D0 (sv) New beads for controlled release and a pharmaceutical preparation containing the same
DE68915088D1 (de) Hydrogenierte, amorphe Materialien und daraus bestehende dünne Filme.
ES2107235T3 (es) Tableta de liberacion prolongada, revestida con pelicula, de astemizol y pseudoefedrina.
NO883837L (no) Anordning til avgivelse av et middel i et foerste tidsrom etterfulgt av et andre, lengre tidsrom.
MX9600857A (es) Forma de dosificacion i en tabletas, con unidades multiples.
TR199800077T1 (xx) Kontroll� ��z�len paroksetin terkipleri.
NO901430L (no) Fremgangsmaate til fremstilling av 4(3h)-pteridioner, og medikamenter inneholdende slike.
DK0839149T3 (da) Galanthamin-derivater, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemidler og farmaceutiske præparater omfattende dem
IT1243193B (it) Composizioni farmaceutiche orali a base di melatonina
DE3873016D1 (de) Optisch aktive, delta-valerolacton-ring enthaltende verbindung und dieselbe enthaltende fluessigkristalline zusammensetzung.
NO882509D0 (no) Nye pyrazolforbindelser og herbicide preparater inneholdende dem som aktive bestanddeler.
ATE80797T1 (de) Hemizellulosematrix enthaltende arzneizubereitungen mit verzoegerter freisetzung.
GR3018795T3 (en) Emulsion-free emulsion polymers in sustained-release pharmaceutical compositions and their production
NO885406L (no) Fremgangsmaate for fremstilling av 4-heteroaryl-1,3-benzodiazepiner og 2-substituerte-alfa-(hetero-aryl)benzenetanaminer og anvendelse derav som medikamenter.
NO894516L (no) Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter.
IT219301Z2 (it) Calendario per agende, diari e simili.
DK564689A (da) Bacillus thuringiensisstammer og fremgangsmaade til fremstilling deraf, samt deres anvendelse som insekticider
DK56484A (da) Farmaceutisk praeparat med forsinket afgivelse og indeholdende pinacidil som primaer aktiv bestanddel
IT8623005V0 (it) Struttura di contenitore in particolare per lumini, candele e/o simili.
JPS5294420A (en) Anti-coccidium agents for livestocks
IT8321118V0 (it) Struttura di dispositivo implantologico, particolarmente per protesi dentarie e simili.
IT8222309V0 (it) Tutore per sostegno ed alimentazione di piante, in particolare di rampicanti.

Legal Events

Date Code Title Description
MA Patent expired